Status:
COMPLETED
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
This prospective, multicenter, observational cohort study will evaluate the efficacy and safety of pegylated interferon alfa (peginterferon alfa) (e.g. Pegasys) plus ribavirin and treatment regimens c...
Eligibility Criteria
Inclusion
- Adult (according to local legislation) participants
- Chronic hepatitis C (HCV)
- Naive or treatment experienced, HIV-HCV co-infected or HCV mono-infected
- Receiving treatment for HCV with pegylated interferons plus ribavirin or regimens containing direct-acting antivirals (DAA) according to standard of care and in line with current SPC/local labeling
Exclusion
- Contraindications according to SPC/local labeling
- Treatment started \>4 weeks before entering study
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
4442 Patients enrolled
Trial Details
Trial ID
NCT01447446
Start Date
September 1 2011
End Date
July 1 2015
Last Update
March 30 2017
Active Locations (271)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp, Belgium, 2018
2
Antwerp, Belgium, 2060
3
Bouge, Belgium, 5004
4
Brussels, Belgium, 1000